USFDA grants approval for Aduhelm as the first and only Alzheimer’s drug in almost two decades – ET HealthWorld

USFDA grants approval for Aduhelm as the first and only Alzheimer’s drug in almost two decades – ET HealthWorld

CAMBRIDGE, Mass. and TOKYO, June 07, 2021 – Biogen and Eisai, Co., Ltd. today announced…

View More USFDA grants approval for Aduhelm as the first and only Alzheimer’s drug in almost two decades – ET HealthWorld